Route 92 Medical

Executive Summary

Route 92 Medical is a private medical device company based in San Mateo, California, focused on improving outcomes for neurovascular patients through advanced catheter-based systems for mechanical thrombectomy in ischemic stroke. Founded in 2015, the company has developed innovative vascular access and intervention technologies designed to enhance procedural efficiency and patient recovery. By rethinking traditional approaches, Route 92 aims to address unmet needs in acute stroke care, including reducing procedure times and improving recanalization rates. The company's proprietary platforms have generated strong interest from interventional neuroradiologists and neurosurgeons, positioning it as a potential leader in the neurovascular device space. As a private entity, Route 92 has not disclosed financials, but its focus on a high-growth market and differentiated technology suggests significant upside potential.

Upcoming Catalysts (preview)

• Q4 2026FDA 510(k) clearance for next-generation thrombectomy system80% success
• Q2 2027Positive results from pivotal clinical trial of Monopoint aspiration catheter65% success
• Q3 2026Strategic partnership with major stroke center network for commercial rollout70% success